Cardinal Health shows exceptional operational performance with 83% increases in both net income and operating income, but concerning liquidity deterioration as operating cash flow plunged 36% and cash reserves declined $1.2B.
The dramatic divergence between record profitability and severely weakened cash generation represents a significant red flag that demands immediate investor attention. This pattern often indicates earnings quality issues, aggressive accounting practices, or unsustainable working capital dynamics that could threaten the company's financial stability despite strong headline earnings.
Cardinal Health delivered outstanding profitability growth with net income surging 83% to $1.6B and operating income matching that gain at $2.3B, while gross profit grew a more modest 10% to $8.2B. However, the company's liquidity position deteriorated sharply with operating cash flow collapsing 36% to $2.4B and cash reserves falling 24% to $3.9B, even as total assets expanded 18% to $53.1B driven primarily by inventory buildup. The stark contradiction between record earnings and deteriorating cash generation, combined with rising debt levels and persistent negative stockholders' equity, signals potential earnings quality concerns that overshadow the impressive profit growth.
Interest expense surged 321.6% — significant debt increase or rising rates materially impacting earnings.
Net income grew 83.2% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Operating cash flow fell 36.3% — earnings quality concerns; investigate working capital changes and non-cash items.
Cash decreased 24.5% — monitor burn rate and upcoming capital needs.
Asset base grew 17.7% — expansion through organic growth, acquisitions, or capital deployment.
Debt rose 17.5% — additional borrowing for investment or operations; monitor coverage ratios.
Equity base grew 13.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Inventory built 12.5% — monitor whether demand supports this build or if write-downs may follow.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →